35-353 Search Results


  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 92
    ATCC sn12c 3 53 tk
    Sn12c 3 53 Tk, supplied by ATCC, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/sn12c 3 53 tk/product/ATCC
    Average 92 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    sn12c 3 53 tk - by Bioz Stars, 2024-04
    92/100 stars
      Buy from Supplier

    93
    Santa Cruz Biotechnology focal adhesion kinase fak sirna
    A , Expression of <t>FAK</t> mRNA is significantly upregulated in left ventricular tissues from patients undergoing hemodialysis, ex vivo. Analysis of FAK mRNA expression by quantitative polymerase chain reaction revealed that FAK was significantly upregulated in hearts from patients undergoing hemodialysis. However, FAK mRNA expression was suppressed in hearts from patients with HTN. B , Expression of FAK protein is upregulated in left ventricular tissues from patients undergoing hemodialysis, ex vivo. Protein expression of FAK was significantly upregulated in hearts from patients undergoing hemodialysis as assessed by immunoblotting. FAK protein expression was significantly suppressed in HTN hearts. C , FAK silencing mediates cytoskeletal dysfunction in the presence of mineral stressors. (i) Primary human ventricular cardiac fibroblasts were transfected once with either scrambled or FAK <t>siRNA.</t> Cells were then treated daily with or without mineral stressors (ie P+Ca: 2 mmol/L β‐glycerophosphate with 1 unit/mL alkaline phosphatase, and 2.7 mmol/L calcium chloride) for 5 days. After treatment, target cytoskeletal proteins were assessed by immunoblotting. (ii) Treatment with FAK siRNA significantly reduced full‐length FAK expression at 5 days, and exposure to high calcium and high phosphate further reduced FAK expression. High calcium and high phosphate treatment resulted in detection of 80 kDa N‐terminal FAK fragment, which was decreased in combined FAK siRNA and high mineral stressors treatment. There was no statistical difference in FAK expression between the control and scrambled siRNA groups. (iii) There was no significant difference in β‐actin expression across the groups. (iv) β‐Tubulin was significantly decreased in cardiac fibroblasts exposed to mineral stressors compared with controls, but was not significantly different in the FAK silencing groups. (v) Vimentin was decreased significantly when cardiac fibroblasts were exposed to high calcium and high phosphate, and further decreased in the FAK silenced group exposed to high calcium and high phosphate. (vi) Expression of vinculin followed a similar pattern to vimentin. D , Schematic diagram of ultrastructural adaptations of the failing myocardium in CKD. In the healthy individuals, interactions between the heart and kidney is critical for normal physiological function. Patients with advanced CKD on hemodialysis (HD) exhibited significant cytoskeletal maladaptations that were generally more severe than hypertensive control hearts. HD hearts exhibited a unique pattern of severely reduced β‐actin, β‐tubulin and upregulation of vinculin expression. Cytoskeletal dysregulation in HD and HTN hearts is associated with mitochondrial dysfunction (reduced OPA1 and MFN1 genes responsible for mitochondrial fusion and division) and loss of cell survival pathways. FAK is a cytosolic tyrosine kinase that plays a central role in regulating cytoskeletal integrity. FAK expression is upregulated in HD hearts. This may account for increased expression of anchor protein vinculin observed as a protective response. GFR indicates glomerular filtration rate.
    Focal Adhesion Kinase Fak Sirna, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/focal adhesion kinase fak sirna/product/Santa Cruz Biotechnology
    Average 93 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    focal adhesion kinase fak sirna - by Bioz Stars, 2024-04
    93/100 stars
      Buy from Supplier

    86
    Santa Cruz Biotechnology fak shrna plasmids
    A , Expression of <t>FAK</t> mRNA is significantly upregulated in left ventricular tissues from patients undergoing hemodialysis, ex vivo. Analysis of FAK mRNA expression by quantitative polymerase chain reaction revealed that FAK was significantly upregulated in hearts from patients undergoing hemodialysis. However, FAK mRNA expression was suppressed in hearts from patients with HTN. B , Expression of FAK protein is upregulated in left ventricular tissues from patients undergoing hemodialysis, ex vivo. Protein expression of FAK was significantly upregulated in hearts from patients undergoing hemodialysis as assessed by immunoblotting. FAK protein expression was significantly suppressed in HTN hearts. C , FAK silencing mediates cytoskeletal dysfunction in the presence of mineral stressors. (i) Primary human ventricular cardiac fibroblasts were transfected once with either scrambled or FAK <t>siRNA.</t> Cells were then treated daily with or without mineral stressors (ie P+Ca: 2 mmol/L β‐glycerophosphate with 1 unit/mL alkaline phosphatase, and 2.7 mmol/L calcium chloride) for 5 days. After treatment, target cytoskeletal proteins were assessed by immunoblotting. (ii) Treatment with FAK siRNA significantly reduced full‐length FAK expression at 5 days, and exposure to high calcium and high phosphate further reduced FAK expression. High calcium and high phosphate treatment resulted in detection of 80 kDa N‐terminal FAK fragment, which was decreased in combined FAK siRNA and high mineral stressors treatment. There was no statistical difference in FAK expression between the control and scrambled siRNA groups. (iii) There was no significant difference in β‐actin expression across the groups. (iv) β‐Tubulin was significantly decreased in cardiac fibroblasts exposed to mineral stressors compared with controls, but was not significantly different in the FAK silencing groups. (v) Vimentin was decreased significantly when cardiac fibroblasts were exposed to high calcium and high phosphate, and further decreased in the FAK silenced group exposed to high calcium and high phosphate. (vi) Expression of vinculin followed a similar pattern to vimentin. D , Schematic diagram of ultrastructural adaptations of the failing myocardium in CKD. In the healthy individuals, interactions between the heart and kidney is critical for normal physiological function. Patients with advanced CKD on hemodialysis (HD) exhibited significant cytoskeletal maladaptations that were generally more severe than hypertensive control hearts. HD hearts exhibited a unique pattern of severely reduced β‐actin, β‐tubulin and upregulation of vinculin expression. Cytoskeletal dysregulation in HD and HTN hearts is associated with mitochondrial dysfunction (reduced OPA1 and MFN1 genes responsible for mitochondrial fusion and division) and loss of cell survival pathways. FAK is a cytosolic tyrosine kinase that plays a central role in regulating cytoskeletal integrity. FAK expression is upregulated in HD hearts. This may account for increased expression of anchor protein vinculin observed as a protective response. GFR indicates glomerular filtration rate.
    Fak Shrna Plasmids, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/fak shrna plasmids/product/Santa Cruz Biotechnology
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    fak shrna plasmids - by Bioz Stars, 2024-04
    86/100 stars
      Buy from Supplier

    86
    Santa Cruz Biotechnology fak sirna
    A , Expression of <t>FAK</t> mRNA is significantly upregulated in left ventricular tissues from patients undergoing hemodialysis, ex vivo. Analysis of FAK mRNA expression by quantitative polymerase chain reaction revealed that FAK was significantly upregulated in hearts from patients undergoing hemodialysis. However, FAK mRNA expression was suppressed in hearts from patients with HTN. B , Expression of FAK protein is upregulated in left ventricular tissues from patients undergoing hemodialysis, ex vivo. Protein expression of FAK was significantly upregulated in hearts from patients undergoing hemodialysis as assessed by immunoblotting. FAK protein expression was significantly suppressed in HTN hearts. C , FAK silencing mediates cytoskeletal dysfunction in the presence of mineral stressors. (i) Primary human ventricular cardiac fibroblasts were transfected once with either scrambled or FAK <t>siRNA.</t> Cells were then treated daily with or without mineral stressors (ie P+Ca: 2 mmol/L β‐glycerophosphate with 1 unit/mL alkaline phosphatase, and 2.7 mmol/L calcium chloride) for 5 days. After treatment, target cytoskeletal proteins were assessed by immunoblotting. (ii) Treatment with FAK siRNA significantly reduced full‐length FAK expression at 5 days, and exposure to high calcium and high phosphate further reduced FAK expression. High calcium and high phosphate treatment resulted in detection of 80 kDa N‐terminal FAK fragment, which was decreased in combined FAK siRNA and high mineral stressors treatment. There was no statistical difference in FAK expression between the control and scrambled siRNA groups. (iii) There was no significant difference in β‐actin expression across the groups. (iv) β‐Tubulin was significantly decreased in cardiac fibroblasts exposed to mineral stressors compared with controls, but was not significantly different in the FAK silencing groups. (v) Vimentin was decreased significantly when cardiac fibroblasts were exposed to high calcium and high phosphate, and further decreased in the FAK silenced group exposed to high calcium and high phosphate. (vi) Expression of vinculin followed a similar pattern to vimentin. D , Schematic diagram of ultrastructural adaptations of the failing myocardium in CKD. In the healthy individuals, interactions between the heart and kidney is critical for normal physiological function. Patients with advanced CKD on hemodialysis (HD) exhibited significant cytoskeletal maladaptations that were generally more severe than hypertensive control hearts. HD hearts exhibited a unique pattern of severely reduced β‐actin, β‐tubulin and upregulation of vinculin expression. Cytoskeletal dysregulation in HD and HTN hearts is associated with mitochondrial dysfunction (reduced OPA1 and MFN1 genes responsible for mitochondrial fusion and division) and loss of cell survival pathways. FAK is a cytosolic tyrosine kinase that plays a central role in regulating cytoskeletal integrity. FAK expression is upregulated in HD hearts. This may account for increased expression of anchor protein vinculin observed as a protective response. GFR indicates glomerular filtration rate.
    Fak Sirna, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/fak sirna/product/Santa Cruz Biotechnology
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    fak sirna - by Bioz Stars, 2024-04
    86/100 stars
      Buy from Supplier

    N/A
    Standard format Plasmid sent in bacteria as agar stab
      Buy from Supplier

    Image Search Results


    A , Expression of FAK mRNA is significantly upregulated in left ventricular tissues from patients undergoing hemodialysis, ex vivo. Analysis of FAK mRNA expression by quantitative polymerase chain reaction revealed that FAK was significantly upregulated in hearts from patients undergoing hemodialysis. However, FAK mRNA expression was suppressed in hearts from patients with HTN. B , Expression of FAK protein is upregulated in left ventricular tissues from patients undergoing hemodialysis, ex vivo. Protein expression of FAK was significantly upregulated in hearts from patients undergoing hemodialysis as assessed by immunoblotting. FAK protein expression was significantly suppressed in HTN hearts. C , FAK silencing mediates cytoskeletal dysfunction in the presence of mineral stressors. (i) Primary human ventricular cardiac fibroblasts were transfected once with either scrambled or FAK siRNA. Cells were then treated daily with or without mineral stressors (ie P+Ca: 2 mmol/L β‐glycerophosphate with 1 unit/mL alkaline phosphatase, and 2.7 mmol/L calcium chloride) for 5 days. After treatment, target cytoskeletal proteins were assessed by immunoblotting. (ii) Treatment with FAK siRNA significantly reduced full‐length FAK expression at 5 days, and exposure to high calcium and high phosphate further reduced FAK expression. High calcium and high phosphate treatment resulted in detection of 80 kDa N‐terminal FAK fragment, which was decreased in combined FAK siRNA and high mineral stressors treatment. There was no statistical difference in FAK expression between the control and scrambled siRNA groups. (iii) There was no significant difference in β‐actin expression across the groups. (iv) β‐Tubulin was significantly decreased in cardiac fibroblasts exposed to mineral stressors compared with controls, but was not significantly different in the FAK silencing groups. (v) Vimentin was decreased significantly when cardiac fibroblasts were exposed to high calcium and high phosphate, and further decreased in the FAK silenced group exposed to high calcium and high phosphate. (vi) Expression of vinculin followed a similar pattern to vimentin. D , Schematic diagram of ultrastructural adaptations of the failing myocardium in CKD. In the healthy individuals, interactions between the heart and kidney is critical for normal physiological function. Patients with advanced CKD on hemodialysis (HD) exhibited significant cytoskeletal maladaptations that were generally more severe than hypertensive control hearts. HD hearts exhibited a unique pattern of severely reduced β‐actin, β‐tubulin and upregulation of vinculin expression. Cytoskeletal dysregulation in HD and HTN hearts is associated with mitochondrial dysfunction (reduced OPA1 and MFN1 genes responsible for mitochondrial fusion and division) and loss of cell survival pathways. FAK is a cytosolic tyrosine kinase that plays a central role in regulating cytoskeletal integrity. FAK expression is upregulated in HD hearts. This may account for increased expression of anchor protein vinculin observed as a protective response. GFR indicates glomerular filtration rate.

    Journal: Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease

    Article Title: Myocardial Cytoskeletal Adaptations in Advanced Kidney Disease

    doi: 10.1161/JAHA.121.022991

    Figure Lengend Snippet: A , Expression of FAK mRNA is significantly upregulated in left ventricular tissues from patients undergoing hemodialysis, ex vivo. Analysis of FAK mRNA expression by quantitative polymerase chain reaction revealed that FAK was significantly upregulated in hearts from patients undergoing hemodialysis. However, FAK mRNA expression was suppressed in hearts from patients with HTN. B , Expression of FAK protein is upregulated in left ventricular tissues from patients undergoing hemodialysis, ex vivo. Protein expression of FAK was significantly upregulated in hearts from patients undergoing hemodialysis as assessed by immunoblotting. FAK protein expression was significantly suppressed in HTN hearts. C , FAK silencing mediates cytoskeletal dysfunction in the presence of mineral stressors. (i) Primary human ventricular cardiac fibroblasts were transfected once with either scrambled or FAK siRNA. Cells were then treated daily with or without mineral stressors (ie P+Ca: 2 mmol/L β‐glycerophosphate with 1 unit/mL alkaline phosphatase, and 2.7 mmol/L calcium chloride) for 5 days. After treatment, target cytoskeletal proteins were assessed by immunoblotting. (ii) Treatment with FAK siRNA significantly reduced full‐length FAK expression at 5 days, and exposure to high calcium and high phosphate further reduced FAK expression. High calcium and high phosphate treatment resulted in detection of 80 kDa N‐terminal FAK fragment, which was decreased in combined FAK siRNA and high mineral stressors treatment. There was no statistical difference in FAK expression between the control and scrambled siRNA groups. (iii) There was no significant difference in β‐actin expression across the groups. (iv) β‐Tubulin was significantly decreased in cardiac fibroblasts exposed to mineral stressors compared with controls, but was not significantly different in the FAK silencing groups. (v) Vimentin was decreased significantly when cardiac fibroblasts were exposed to high calcium and high phosphate, and further decreased in the FAK silenced group exposed to high calcium and high phosphate. (vi) Expression of vinculin followed a similar pattern to vimentin. D , Schematic diagram of ultrastructural adaptations of the failing myocardium in CKD. In the healthy individuals, interactions between the heart and kidney is critical for normal physiological function. Patients with advanced CKD on hemodialysis (HD) exhibited significant cytoskeletal maladaptations that were generally more severe than hypertensive control hearts. HD hearts exhibited a unique pattern of severely reduced β‐actin, β‐tubulin and upregulation of vinculin expression. Cytoskeletal dysregulation in HD and HTN hearts is associated with mitochondrial dysfunction (reduced OPA1 and MFN1 genes responsible for mitochondrial fusion and division) and loss of cell survival pathways. FAK is a cytosolic tyrosine kinase that plays a central role in regulating cytoskeletal integrity. FAK expression is upregulated in HD hearts. This may account for increased expression of anchor protein vinculin observed as a protective response. GFR indicates glomerular filtration rate.

    Article Snippet: Human ventricular cardiac fibroblasts were serum starved for 24 hours prior to transfection with either focal adhesion kinase (FAK) siRNA (Cat. No. sc‐29310; Santa Cruz Biotechnology, Dallas, TX) or siRNA‐B (Cat. No. sc‐44230; Santa Cruz Biotechnology, Dallas, TX).

    Techniques: Expressing, Ex Vivo, Real-time Polymerase Chain Reaction, Western Blot, Transfection, Filtration